July 25, 2016 1:31 AM ET


Company Overview of Syndax Pharmaceuticals, Inc.

Executive Profile

Michael A. Metzger MBA

President and Chief Operating Officer, Syndax Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 6 different industries.

As of Fiscal Year 2015


Mr. Michael A. Metzger, M.B.A. has been President and Chief Operating Officer at Syndax Pharmaceuticals, Inc. since May 5, 2015. Mr. Metzger served as Chief Executive Officer, President and Chief Operating Officer of Tobira Therapeutics, Inc. since May 04, 2015. He served as the Chief Executive Officer of Regado Biosciences, Inc. since October 10, 2014, President since December 5, 2013 and Chief Operating Officer since December 5, 2013. He served as an Executive Vice ...

Corporate Headquarters

400 Totten Pond Road
Waltham, Massachusetts 02451

United States

Phone: 781-419-1400
Fax: 781-419-1420

Board Members Memberships

There is no Board Members Memberships data available.


The George Washington University
New York University - Leonard N. Stern School of Business

Other Affiliations

Annual Compensation

Total Annual Compensation$346,538

Stocks Options

Exercisable Options$607,802
Total Number of Options$607,802

Total Compensation

Total Annual Cash Compensation$346,538
Total Short Term Compensation$346,538
Total Calculated Compensation$2,896,695

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.